Stock Region Penny Picks
Stock Region Penny Picks Watchlist Newsletter - Monday, March 17, 2025.
Stock Region Penny Picks Watchlist Newsletter - Monday, March 17, 2025
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The information provided in this newsletter is for informational purposes only and should not be considered financial advice or a recommendation to buy, sell, or hold any securities. Always do your own research or consult a financial advisor before making investment decisions.
$CREX - Creative Realities
Creative Realities has announced a settlement agreement with Reflect Systems. This update could signal a resolution that allows CREX to focus on its growth initiatives without ongoing legal distractions. Keep an eye on future developments.
$CVM - CEL-SCI Corporation
CEL-SCI's head and neck cancer registration study protocol has officially cleared FDA review. The company is now in discussions with potential partners interested in commercializing Multikine. A significant step forward for CVM and its innovative therapy.
$HYPR - Hyperfine
Hyperfine is teaming up with NVIDIA to revolutionize neuroimaging through AI-powered innovation. Such a major leap into advanced medical imaging technology, potentially broadening HYPR's impact in the healthcare sector.
$ANTE - AirNet
AirNet has entered a non-binding investment letter of intent with LLP STH Corp to develop a large-scale, liquid-cooled Bitcoin mining farm in Kazakhstan with a 130MW capacity. This venture could position ANTE as a notable player in the cryptocurrency mining industry.
$SOAR - SOAR Technology
SOAR Technology has requested the withdrawal of its registration statement. The details behind this decision remain limited, but this action might influence investor sentiment in the short term. Keep monitoring for further updates or clarifications.
$MGRM - Monogram Technologies
Monogram Technologies has received FDA 510(k) clearance for its Monogram mBôs™ TKA System. This approval marks a critical advancement in Monogram's surgical technology, paving the way for potential market growth and adoption.
Disclaimer: Past performance is not indicative of future results. Stock trading involves risk, and you could lose money. Stock Region does not accept liability for any losses incurred as a result of using our content. Always evaluate your investment goals and consider seeking advice from a licensed financial professional.
We are working endlessly to provide free insights on the stock market every day, and greatly appreciate those who are paid members supporting the development of the Stock Region mobile application. Stock Region offers daily stock and option signals, watchlists, earnings reports, technical and fundamental analysis reports, virtual meetings, learning opportunities, analyst upgrades and downgrades, catalyst reports, in-person events, and access to our private network of investors for paid members as an addition to being an early investor in Stock Region. We recommend all readers to urgently activate their membership before reaching full member capacity (500) to be eligible for the upcoming revenue distribution program. Memberships now available at https://stockregion.net